Literature DB >> 29845377

Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration.

David Castanedo-Vazquez1, Pilar Bosque-Varela2, Arancha Sainz-Pelayo3, Javier Riancho4,5.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease affecting motor neurons (MN). This fatal disease is characterized by progressive muscle wasting and lacks an effective treatment. ALS pathogenesis has not been elucidated yet. In a small proportion of ALS patients, the disease has a familial origin, related to mutations in specific genes, which directly result in MN degeneration. By contrast, the vast majority of cases are though to be sporadic, in which genes and environment interact leading to disease in genetically predisposed individuals. Lately, the role of the environment has gained relevance in this field and an extensive list of environmental conditions have been postulated to be involved in ALS. Among them, infectious agents, particularly viruses, have been suggested to play an important role in the pathogenesis of the disease. These agents could act by interacting with some crucial pathways in MN degeneration, such as gene processing, oxidative stress or neuroinflammation. In this article, we will review the main studies about the involvement of microorganisms in ALS, subsequently discussing their potential pathogenic effect and integrating them as another piece in the puzzle of ALS pathogenesis.

Entities:  

Keywords:  ALS; Amyotrophic lateral sclerosis; Bacteria; Fungi; Infection; Microorganisms; Parasites; Viruses

Mesh:

Year:  2018        PMID: 29845377     DOI: 10.1007/s00415-018-8919-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  80 in total

Review 1.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

2.  Direct visualization of fungal infection in brains from patients with Alzheimer's disease.

Authors:  Diana Pisa; Ruth Alonso; Angeles Juarranz; Alberto Rábano; Luis Carrasco
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Update on Neurological Manifestations of HTLV-1 Infection.

Authors:  Abelardo Q-C Araujo
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

Review 4.  Amyotrophic lateral sclerosis: moving towards a new classification system.

Authors:  Ammar Al-Chalabi; Orla Hardiman; Matthew C Kiernan; Adriano Chiò; Benjamin Rix-Brooks; Leonard H van den Berg
Journal:  Lancet Neurol       Date:  2016-10       Impact factor: 44.182

Review 5.  Sporadic amyotrophic lateral sclerosis: a hypothesis of persistent (non-lytic) enteroviral infection.

Authors:  John Ravits
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2005-06

6.  Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.

Authors:  S J Murch; P A Cox; S A Banack; J C Steele; O W Sacks
Journal:  Acta Neurol Scand       Date:  2004-10       Impact factor: 3.209

Review 7.  The changing scene of amyotrophic lateral sclerosis.

Authors:  Wim Robberecht; Thomas Philips
Journal:  Nat Rev Neurosci       Date:  2013-03-06       Impact factor: 34.870

8.  Endogenous retroviruses in ALS: A reawakening?

Authors:  Robert H Brown; Ammar Al-Chalabi
Journal:  Sci Transl Med       Date:  2015-09-30       Impact factor: 17.956

Review 9.  HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.

Authors:  L P Rowland
Journal:  Acta Myol       Date:  2011-06

Review 10.  Redox Imbalance and Viral Infections in Neurodegenerative Diseases.

Authors:  Dolores Limongi; Sara Baldelli
Journal:  Oxid Med Cell Longev       Date:  2016-03-27       Impact factor: 6.543

View more
  6 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

Review 2.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

Review 3.  The enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases.

Authors:  Noah Lubben; Elizabeth Ensink; Gerhard A Coetzee; Viviane Labrie
Journal:  Brain Commun       Date:  2021-09-06

Review 4.  Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis.

Authors:  Belgin Sever; Halilibrahim Ciftci; Hasan DeMirci; Hilal Sever; Firdevs Ocak; Burak Yulug; Hiroshi Tateishi; Takahisa Tateishi; Masami Otsuka; Mikako Fujita; Ayşe Nazlı Başak
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

5.  High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis, and Motor Neuron Diseases Indicate Common Causative Factors.

Authors:  Lisa M James; Apostolos P Georgopoulos
Journal:  Neurosci Insights       Date:  2022-08-08

6.  Application of a bioinformatic pipeline to RNA-seq data identifies novel virus-like sequence in human blood.

Authors:  Marko Melnick; Patrick Gonzales; Thomas J LaRocca; Yuping Song; Joanne Wuu; Michael Benatar; Björn Oskarsson; Leonard Petrucelli; Robin D Dowell; Christopher D Link; Mercedes Prudencio
Journal:  G3 (Bethesda)       Date:  2021-09-06       Impact factor: 3.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.